EP3315124
BILAYER TABLET FORMULATIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
12.11.2010:
6.1.2021:
17206106.1
:
11.11.2030
:
BILAYER TABLET FORMULATIONS
12.11.2010
6.1.2021
:
Astrazeneca AB:
151 85 Södertälje, SE
:
AstraZeneca UK Limited:
1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA, GB
:
ABEBE, Admassu:
Princeton, NJ 08543, US
:
MARTIN, Kyle:
Princeton, NJ 08543, US
:
PATEL, Jatin M.:
Princeton, NJ 08543, US
:
DESAI, Divyakant:
Princeton, NJ 08543, US
:
TIMMINS, Peter:
Princeton, NJ 08543, US
:
261087 P:
13.11.2009:
US
:
A61K 9/24, A61K 31/155, A61K 31/70, A61K 31/7034, A61K 31/7042, A61K 31/7004, A61K 31/403, A61K 45/06, A61P 3/00, A61P 3/04, A61P 3/06, A61P 3/10, A61P 5/50, A61P 9/10, A61P 9/12, A61P 13/12, A61P 17/02, A61P 25/00, A61P 27/02, A61P 27/12, A61P 43/00, A61K 9/20